BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

924 related articles for article (PubMed ID: 11042656)

  • 21. Prophylactic red blood cell exchange for prevention of severe immune hemolysis in minor ABO-mismatched allogeneic peripheral blood progenitor cell transplantation after reduced-intensity conditioning.
    Worel N; Greinix HT; Supper V; Leitner G; Mitterbauer M; Rabitsch W; Fischer G; Rosenmayr A; Höcker P; Kalhs P
    Transfusion; 2007 Aug; 47(8):1494-502. PubMed ID: 17655594
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transfusion requirements after bone marrow transplantation from HLA-identical siblings: effects of donor-recipient ABO incompatibility.
    Mehta J; Powles R; Singhal S; Horton C; Hamblin M; Zomas A; Saso R; Treleaven J
    Bone Marrow Transplant; 1996 Jul; 18(1):151-6. PubMed ID: 8832008
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Major ABO-incompatible hematopoietic stem cell transplantation: study of post-transplant pure red cell aplasia and endothelial cell chimerism.
    Mueller RJ; Stussi G; Odermatt B; Halter J; Schanz U; Seebach JD
    Xenotransplantation; 2006 Mar; 13(2):126-32. PubMed ID: 16623806
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of ABO incompatibility on allogeneic peripheral blood progenitor cell transplantation after reduced intensity conditioning.
    Canals C; Muñiz-Díaz E; Martínez C; Martino R; Moreno I; Ramos A; Arilla M; Boto N; Pastoret C; Remacha A; Sierra J; Madoz P
    Transfusion; 2004 Nov; 44(11):1603-11. PubMed ID: 15504166
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between donor-recipient blood group incompatibility and serum bilirubin after allogeneic bone marrow transplantation from HLA-identical siblings.
    Mehta J; Powles R; Horton C; Milan S; Singhal S; Treleaven J
    Bone Marrow Transplant; 1995 Jun; 15(6):853-8. PubMed ID: 7581080
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pure red-cell aplasia following major and bi-directional ABO-incompatible allogeneic stem-cell transplantation: recovery of donor-derived erythropoiesis after long-term treatment using different therapeutic strategies.
    Helbig G; Stella-Holowiecka B; Wojnar J; Krawczyk M; Krzemien S; Wojciechowska-Sadus M; Markiewicz M; Wylezol I; Kopera M; Holowiecki J
    Ann Hematol; 2007 Sep; 86(9):677-83. PubMed ID: 17486341
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and impact of donor-type red blood cell transfusion before allogeneic peripheral blood progenitor cell transplantation with major ABO mismatch.
    Scholl S; Klink A; Mügge LO; Schilling K; Höffken K; Sayer HG
    Transfusion; 2005 Oct; 45(10):1676-83. PubMed ID: 16181220
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peripheral blood or bone marrow cells in reduced-intensity or myeloablative conditioning allogeneic HLA identical sibling donor transplantation for multiple myeloma.
    Gahrton G; Iacobelli S; Bandini G; Björkstrand B; Corradini P; Crawley C; Hegenbart U; Morgan G; Kröger N; Schattenberg A; Schönland SO; Verdonck LF; Volin L; de Witte T; Niederwieser D;
    Haematologica; 2007 Nov; 92(11):1513-8. PubMed ID: 18024400
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Massive hemolysis following allogeneic peripheral blood stem cell transplantation with minor ABO incompatibility].
    Ishiyama M; Iwabe K; Hida M; Okamura T; Yoshinaga K; Hidai H; Kobayashi S; Sameshima Y; Mori N; Teramura M; Masuda M; Motoji T; Mizoguchi H
    Rinsho Ketsueki; 2002 Jun; 43(6):477-81. PubMed ID: 12134705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of HLA-identity on results of ABO-incompatible living kidney transplantation.
    Shimmura H; Tanabe K; Tokumoto T; Ishida H; Ishikawa N; Miyamoto N; Shimizu T; Shirakawa H; Setoguchi K; Teraoka S; Toma H
    Transplant Proc; 2004 Sep; 36(7):2172-4. PubMed ID: 15518790
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ABO-histo blood group incompatibility in hematopoietic stem cell and solid organ transplantation.
    Stussi G; Halter J; Schanz U; Seebach JD
    Transfus Apher Sci; 2006 Aug; 35(1):59-69. PubMed ID: 16935028
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The transfusion aspects of allogeneic bone marrow transplantation].
    Fregatova LM; Volkova OIa; Shavva SA; Platonova GG; Afanas'ev BV
    Ter Arkh; 1998; 70(7):67-9. PubMed ID: 9742642
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Erythrocyte repopulation after major ABO incompatible transplantation with lymphocyte-depleted bone marrow.
    Bär BM; Van Dijk BA; Schattenberg A; de Man AJ; Kunst VA; de Witte T
    Bone Marrow Transplant; 1995 Dec; 16(6):793-9. PubMed ID: 8750272
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adult ABO-incompatible liver transplantation, using A and B donors.
    Skogsberg U; Breimer ME; Friman S; Mjörnstedt L; Mölne J; Olausson M; Rydberg L; Svalander CT; Bäckman L
    Xenotransplantation; 2006 Mar; 13(2):154-9. PubMed ID: 16623811
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is the ABO incompatibility a risk factor in bone marrow transplantation?
    Rozman P; Kosir A; Bohinjec M
    Transpl Immunol; 2005 Aug; 14(3-4):159-69. PubMed ID: 15982558
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bone marrow transplantation with major ABO incompatibility. Experience of the Bone Marrow Transplantation Unit--Francisco Gentil Portuguese Institute of Oncology, Lisbon Centre.
    Coelho R; Cunha I; Nolasco I; Machado A; Abecassis M
    Acta Med Port; 1994 Dec; 7 Suppl 1():S21-4. PubMed ID: 7653275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pre-transplant reduction of isohaemagglutinin titres by donor group plasma infusion does not reduce the incidence of pure red cell aplasia in major ABO-mismatched transplants.
    Damodar S; George B; Mammen J; Mathews V; Srivastava A; Chandy M
    Bone Marrow Transplant; 2005 Aug; 36(3):233-5. PubMed ID: 15908965
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Isoagglutinins after bone marrow transplantation with minor ABO incompatibility].
    Wernet D; Mayer G
    Beitr Infusionsther; 1992; 30():359-62. PubMed ID: 1284734
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ABO-incompatible bone marrow transplantation: prevention of hemolysis by alkaline hydration with mannitol diuresis in conjunction with red cell reduced buffy coat bone marrow.
    Slavc I; Urban C; Schwinger W; Hauer C; Vadon M
    Wien Klin Wochenschr; 1992; 104(4):93-6. PubMed ID: 1570714
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Successful treatment of pure red cell aplasia after major ABO-incompatible T cell-depleted bone marrow transplantation with erythropoietin.
    Santamaría A; Sureda A; Martino R; Domingo-Albós A; Muñiz-Díaz E; Brunet S
    Bone Marrow Transplant; 1997 Dec; 20(12):1105-7. PubMed ID: 9466287
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 47.